Skip to main content
Caplight Logo









Orthox

Orthox

Private
AbingdonHealthcare & Life Scienceshttps://orthox.com/

Last Round

Series A

Feb 9, 2022

Total Funding Raised

$33.19M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Orthox is a medical technology company that develops tissue regenerative implants for cartilage and bone repair.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

orthopedic implantsregenerative medicinecartilage repairmedical devicebiomaterialsbiodegradable implantsmeniscus repairtissue engineeringjoint repairfibroinscaffold technologysports medicinebiotechmedtechclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orthox Comparables

Compare Orthox with similar companies based on industry and business-model similarity.

Orthox comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hy2Care
89%
Orteq Sports Medicine
88%
Nanochon
87%

Orthox Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 9, 2022
GrantNov 1, 2019
GrantApr 1, 2017
SeedJun 30, 2015
GrantJul 11, 2014
Grant
Oct 29, 2013

Key People

Founding team and executive leadership

Nick Skaer

Founder and CEO

Founding Team

Orthox Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 442% MoM, from 481 to 2.6K.

  • Apr 17, 2026

    Monthly visitors increased 58% MoM, from 1.3K to 2K.

Orthox Filings

Explore SEC and related filing metadata, where available.

Orthox filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Orthox's valuation, stock price, and market status.

Is Orthox a public or private company?

Orthox is a private company.

What is the current stock price of Orthox?

Orthox is a private company with no public stock price. No recent secondary market data is available.

How much is Orthox worth (valuation)?

Valuation information for Orthox is not publicly available.

Can I buy Orthox stock?

Orthox shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Orthox's last funding round?

Orthox's most recent funding round was Series A on February 9, 2022.

Who are the main investors in Orthox?

Key investors in Orthox include Parkwalk Advisors.

Will Orthox IPO soon?

No public IPO plans have been announced for Orthox.

How can I track Orthox secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Orthox's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAbingdon
Employee Range9
Year Founded2008
Last FundingFeb 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?